Literature DB >> 10885821

Epidemiology of resistant tuberculosis in Europe.

S Rüsch-Gerdes1.   

Abstract

About one-third of the world's population has been infected with Mycobacterium tuberculosis (MTB). Active disease develops in eight to ten million people per year, and tuberculosis is responsible for three million deaths every year. This makes it the leading cause of death due to infections in the world. In 1996, 315,892 cases of tuberculosis were reported in 50 countries of the WHO European region. The notification rate was less than 20 per 100,000 in 21 countries, all of which are situated in the western part of Europe except the Czech Republic and Israel. The rate was 20 cases per 100,000 or more in 29 countries located in the eastern part of Europe except for Portugal and Spain. In addition to the rise of tuberculosis observed worldwide, the emergence of drug-resistant tuberculosis (TB) poses a major threat to TB control efforts. The prevalence of resistance is increasing dramatically, predominantly in eastern Europe. The aim of this article is to describe the situation of resistant TB in Europe, and to point out reasons for the increase of drug-resistant MTB strains.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10885821     DOI: 10.1007/BF02561664

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  4 in total

1.  Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology.

Authors:  J D van Embden; M D Cave; J T Crawford; J W Dale; K D Eisenach; B Gicquel; P Hermans; C Martin; R McAdam; T M Shinnick
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

2.  IS6110 fingerprinting of drug-resistant Mycobacterium tuberculosis strains isolated in Germany during 1995.

Authors:  S Niemann; S Rüsch-Gerdes; E Richter
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

3.  Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods.

Authors:  D Alland; G E Kalkut; A R Moss; R A McAdam; J A Hahn; W Bosworth; E Drucker; B R Bloom
Journal:  N Engl J Med       Date:  1994-06-16       Impact factor: 91.245

4.  Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in an immunocompetent patient.

Authors:  R W Shafer; S P Singh; C Larkin; P M Small
Journal:  Tuber Lung Dis       Date:  1995-12
  4 in total
  4 in total

1.  Evaluation of automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to four major antituberculous drugs: comparison with the radiometric BACTEC 460TB method and the agar plate method of proportion.

Authors:  Enrico Tortoli; Marta Benedetti; Alessandra Fontanelli; M Tullia Simonetti
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

2.  Clinical concentrations of thioridazine kill intracellular multidrug-resistant Mycobacterium tuberculosis.

Authors:  Diane Ordway; Miguel Viveiros; Clara Leandro; Rosário Bettencourt; Josefina Almeida; Marta Martins; Jette E Kristiansen; Joseph Molnar; Leonard Amaral
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

3.  Interleukin-8 secretion from Mycobacterium tuberculosis-infected monocytes is regulated by protein tyrosine kinases but not by ERK1/2 or p38 mitogen-activated protein kinases.

Authors:  Clara Ameixa; Jon S Friedland
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

4.  Drug-resistant tuberculosis in a tertiary referral teaching hospital of Korea.

Authors:  J H Lee; J H Chang
Journal:  Korean J Intern Med       Date:  2001-09       Impact factor: 2.884

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.